A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil
Status:
Withdrawn
Trial end date:
2020-05-22
Target enrollment:
Participant gender:
Summary
The purpose of the study in Part 1, is to evaluate (under fasted conditions) the plasma
pharmacokinetics (PK) of padsevonil (PSL) using 4 PSL product variants against a PSL
reference tablet and in Part 2, to evaluate the PK of PSL using a PSL reference tablet under
fed and fasted conditions at 200 mg and 400 mg.